Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HBsAg

Molecular Immunology

Volumn 42, Issue 1, 2005, Pages 99-104

  Iglesias, Enrique ^a   Aguilar, Julio C ^a   Cruz, Luis J ^a   Reyes, Osvaldo ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Cross reacting antibodies; Cross reaction; HIV 1; Multiple antigen peptide; V3 loop

Indexed keywords

ARGINYLGLUTAMINYLSERYLTHREONYLPROLYLISOLEUCYLGLYCYLLEUCYLGLYCYLGLUTAMINYL ALANYLLEUCYLTYROSYLTHREONYLTHREONINE; ARGINYLLYSYLARGINYLISOLEUCYLHISTIDYLISOLEUCYLGLYCYLPROLYLGLYCYLARGINYL ALANYLPHENYLALANYLTYROSYLTHREONYLTHREONINE; ARGINYLLYSYLARGINYLISOLEUCYLTHREONYLMETHIONYLGLYCYLPROLYLGLYCYLTHREONYL VALYLTYROSYLTYROSYLTHREONYLTHREONINE; ARGINYLLYSYLSERYLISOLEUCYLTHREONYLLYSYLGLYCYLPROLYLGLYCYLARGINYLVALYL ISOLEUCYLTYROSYLALANYLTHREONINE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; PEPTIDE; SERYLARGINYLGLYCYLISOLEUCYLARGINYLISOLEUCYLGLYCYLPROLYLGLYCYLARGINYLALANYL ISOLEUCYLLEUCYLALANYLTHREONINE; SERYLISOLEUCYLARGINYLISOLEUCYLGLUTAMINYLARGINYLGLYCYLPROLYLGLYCYLARGINYL ALANYLPHENYLALANYLVALYLTHREONYLISOLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CONJUGATE; CONJUGATION; CONTROLLED STUDY; CROSS REACTION; FEMALE; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; VACCINE PRODUCTION;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; CROSS REACTIONS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HIV ENVELOPE PROTEIN GP120; IMMUNIZATION; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PROTEIN ENGINEERING; VACCINES, SYNTHETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 5444270728     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.06.038     Document Type: Article

References (22)

1. D. Bhattacharyya, B.R. Brooks, and L. Callahan Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype AIDS Res. Hum. Retroviruses 12 1996 83 90
2. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
3. M.K. Bray, S.T. Degraw, N.D. Frizzell, S.R. Hoffman, and R.A. Houghten Simultaneous multiple peptide synthesis: the rapid preparation of large numbers of discrete peptides for biological, immunological, and methodological studies Biotechniques 4 1996 522 528
4. L.J. Cruz, E. Iglesias, J.C. Aguilar, L.J. Gonzalez, O. Reyes, F. Albericio, and D. Andreu A comparative study of different presentation strategies for an HIV peptide immunogen Bioconjug. Chem. 15 2004 112 120
5. L.J. Cruz, E. Iglesias, J.C. Aguilar, D. Quintana, H.E. Garay, C. Duarte, and O. Reyes Study of different coupling agents in the conjugation of a V3-based synthetic MAP to carrier proteins J. Pept. Sci. 7 2001 511 518
6. L.J. Cruz, D. Quintana, E. Iglesias, Y. Garcia, V. Huerta, H.E. Garay, C. Duarte, and O. Reyes Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice J. Pept. Sci. 6 2000 217 224
7. G. Del Giudice, C. Tougne, J.A. Louis, P.H. Lambert, E. Bianchi, F. Bonelli, L. Chiappinelli, and A. Pessi A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes Eur. J. Immunol. 20 1990 1619 1622
8. C.E. Gomez, A.E. Lopez-Campistrous, and C.A. Duarte An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera J. Virol. Methods 71 1998 7 16
9. G.J. Gorse, M.C. Keefer, R.B. Belshe, T.J. Matthews, B.D. Forrest, R.H. Hsieh, W.C. Koff, C.V. Hanson, R. Dolin, K.J. Weinhold, S.E. Frey, N. Ketter, and P.E. Fast A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group J. Infect. Dis. 173 1996 330 339
10. C. Holm-Hansen, E. Baan, B. Asjo, F.R. Pascu, J. Goudsmit, and J.J. De Jong Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region AIDS Res. Hum. Retroviruses 16 2000 867 870
11. L.A. Ivanoff, D.J. Looney, C. McDanal, J.F. Morris, F. Wong-Staal, A.J. Langlois, S.R. Petteway Jr., and T.J. Matthews Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain AIDS Res. Hum. Retroviruses 7 1991 595 603
12. K. Javaherian, A.J. Langlois, C. McDanal, K.L. Ross, L.I. Eckler, C.L. Jellis, A.T. Profy, J.R. Rusche, D.P. Bolognesi, and S.D. Putney Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein Proc. Natl. Acad. Sci. USA 86 1989 6768 6772
13. N.L. Letvin, S. Robinson, D. Rohne, M.K. Axthelm, J.W. Fanton, M. Bilska, T.J. Palker, H.X. Liao, B.F. Haynes, and D.C. Montefiori Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope J. Virol. 75 2001 4165 4175
14. F. Mammano, F. Salvatori, L. Ometto, M. Panozzo, L. Chieco-Bianchi, and A. De Rossi Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1 J. Virol. 69 1995 82 92
15. A. McKnight, R.A. Weiss, C. Shotton, Y. Takeuchi, H. Hoshino, and P.R. Clapham Change in tropism upon immune escape by human immunodeficiency virus J. Virol. 69 1995 3167 3170
16. P.L. Nara, and J. Goudsmit Clonal dominance of the neutralizing response to the HIV-1 V3 epitope: evidence for original antigenic sin during vaccination and infection in animals, including humans R.A. Lerner H.S. Ginsberg R.M. Chanock F. Brown Vaccines 91 1991 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York 51 55
17. E.H. Nardin, G.A. Oliveira, J.M. Calvo-Calle, and R.S. Nussenzweig The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases Adv. Immunol. 60 1995 105 149
18. K.A. Page, S.M. Stearns, and D.R. Littman Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity J. Virol. 66 1992 524 533
19. A. Rubinstein, Y. Mizrachi, M. Pettoello-Mantovani, J. Lenz, G.Q. Liu, Y. Rubinstein, H. Goldstein, I. Yust, M. Burke, N. Vardinon, Z. Spirer, and S.J. Cryz Jr. Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates J. Acquir. Immune Defic. Syndr. 22 1999 467 476
20. M. Schreiber, C. Wachsmuth, H. Muller, C. Hagen, H. Schmitz, and J. van Lunzen Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression J. Gen. Virol. 77 1996 2403 2414
21. T.L. Smith, E.J. van Rensburg, and S. Engelbrecht Neutralization of HIV-1 subtypes: implications for vaccine formulations J. Med. Virol. 56 1998 264 268
22. T. Yamanaka, Y. Fujimura, S. Ishimoto, A. Yoshioka, M. Konishi, N. Narita, J. Mimaya, T. Meguro, T. Nakasone, Y. Okamoto, H. Yoshizaki, K. Yamada, and M. Honda Correlation of titer of antibody to principal neutralizing domain of HIVMN strain with disease progression in Japanese hemophiliacs seropositive for HIV type 1 AIDS Res. Hum. Retroviruses 13 1997 317 326